Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

What do taller children eat? A study of 1.7 million students offers clues

18

Nov 2026

What do taller children eat? A study of 1.7 million students offers clues

An observational study of approximately 1.7 million Chinese students identified a dietary pattern rich in fruits, nuts, eggs, and milk (FUEL) that was associated with greater height, lower environmental impacts, and relatively low food costs. The findings suggest that nutritional quality and diversity, rather than total calorie supply alone, may help explain differences in childhood and adolescent growth.

From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?

18

Nov 2026

From paint thinners to fuels: Could workplace chemicals play a role in Parkinson’s disease?

In a cross-sectional study of 41,315 US participants, researchers identified associations between occupational exposure to four industrial solvents, trichloroethylene, kerosene, carbon tetrachloride, and mineral spirits, and higher odds of Parkinson’s disease after accounting for other solvent exposures. The odds increased with the number of solvents reported, but limitations in exposure assessment, age-related confounding, and self-reported diagnoses prevented the researchers from establishing causality.

Can teenagers be “fat but fit”? What eight weeks of school exercise revealed

18

Nov 2026

Can teenagers be “fat but fit”? What eight weeks of school exercise revealed

An eight-week school-based high-intensity interval training (HIIT) study involving 98 adolescents found modest gains in cardiorespiratory fitness across all weight and fitness categories, but inconsistent improvements in cardiovascular health and body composition. Higher initial fitness did not reliably predict more favorable cardiovascular changes, raising questions about whether the “fat but fit” concept applies to short-term exercise responses.

COVID-19 and the teenage brain: Why the severity of symptoms may matter

18

Nov 2026

COVID-19 and the teenage brain: Why the severity of symptoms may matter

A cross-sectional study of 3,860 Austrian adolescents found that more severe COVID-19 symptoms were associated with lower scores on logical reasoning and numerical ability, with lower verbal performance particularly evident among girls. Neither infection occurrence nor frequency was significantly associated with cognitive performance, and further research is needed to establish causality and determine whether these cognitive differences persist over time.

Urgent action needed as antibiotic-resistant bacteria spread across Europe

18

Nov 2026

Urgent action needed as antibiotic-resistant bacteria spread across Europe

With mounting evidence that antibiotic-resistant bacteria are continuing to spread and treatment options are becoming increasingly limited, urgent action is needed to safeguard the effectiveness of antibiotics, the European Centre for Disease Prevention and Control (ECDC) said on the occasion of European Antibiotic Awareness Day.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.